2023. Correlation Analysis of DNA UGT1A1 Gene Expression in Hyperbilirubinemia and Central Nervous System-Related Adverse Reactions Following Oral Dolutegravir Administration. Medinformatics. 1, 1 (Oct. 2023), 35–42. DOI:https://doi.org/10.47852/bonviewMEDIN32021466.